The expression and clinical benefit of TGF*"β1 in the gestational trophoblastic disease
- VernacularTitle:转化生长因子β1在妊娠滋养细胞疾病中的表达及临床意义
- Author:
Qiling LI
;
Huixi LIU
- Publication Type:Journal Article
- From:
Journal of Xi'an Jiaotong University(Medical Sciences)
2001;22(2):143-144,156
- CountryChina
- Language:Chinese
-
Abstract:
To determine whether TGF*"β1 has any possible correlation with occurrence and development of gestational trophoblastic disease. Methods Immunohistologic staining for TGF*"β1 was performed on archival materials from 10 cases of first trimester villi, 40 hydatidiform mole, 10 invasive mole and 6 gestational choriocarcinoma. Results It was shown that the positive rate of TGF*"β1 was 100% in the first trimester villi, 95% in hydatidiform mole, 80% in invasive mole and 66.7% in gestational choriocarcinoma. In hydatidiform mole group, the staining intensity on TGF*"β1 wasn't associated with histologic grade (P＞0.05). Conclusion As a negative regulator of cell proliferation, TGF*"β1 may play an important role in the inhibition of proliferation and invasion of trophoblastic cells and of GTD malignant transformation process. TGF*"β1 isn't associated with prognostic of hydatidiform mole.
